Zai Lab hits the road for $150m ADS follow-on

Jonathan Breen

September 03, 2018 10:30 am

Capsules_230px

Chinese biotechnology firm Zai Lab is tapping equity investors for around $150m, hitting the market with a follow-on sale of American Depository Shares (ADS).

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

JP Morgan Equity China Americas Citi Jefferies LLC Asia Follow-ons and Rights Issues Asia Greater China Northeast Asia Asia Pacific United States Follow-ons and Rights issues Emerging Markets North America

JB

Jonathan Breen

Equities editor GlobalCapital Asia